Genomatix Takes A Lead In Next Generation Sequencing

Main Category: Genetics
Article Date: 01 Feb 2008 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Genomatix is a company with a renowned track record in the analysis of genomic data generated by high throughput technologies. Genomatix algorithms include optimized fast mapping strategies and Genomatix already provides the most complete genome annotation in terms of transcriptome and promoters available in its ElDorado database surpassing alternative databases in this specific content by a factor of 2 to 4.

Pilot studies in collaboration with customers, successfully analyzing Next Generation Sequencing data (from 454 and Solexa) have firmly established that ElDorado brings a dramatic advantage to NGS data processing and interpretation, providing additional information about the transcriptome and its regulation. Result data can be visualized by ElDorado in the full genomic annotation context and a variety of correlation studies and further downstream analyses are possible using other established Genomatix services.

Genomatix has announce that services for NGS studies are available within our consulting model, effective immediately, including Digital Gene Expression (DGE) Studies as well as Chip Sequencing (ChiPSeq) Assays. Inquiries are welcome.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Source: Peter Grant
Genomatix Software GmbH